跳至主要内容
临床试验/IRCT2015030821355N1
IRCT2015030821355N1已完成3 期

levetiracetam versus carbamazepine monotherapy in the treatment of focal epilepsy of children

Mashhad University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 year 至 16 years(—)
性别
All

入选标准

  • Children with age over one year and less than sixteen years old with newly diagnosed focal epilepsy, No history of refractory seizures, No history of renal disease, No history of hepatic disease, No history of cerebral palsy, No history of antiepileptic drug consumption.
  • Exclusion criteria: Pseudo- seizures, Skin rash especially Stevens Johnson syndrome, Drug-induced hepatitis, Acute psychosis, Renal disorders, Severe agitation, any other mild side effects that is unbearable to the patient or parents

排除标准

  • 未提供

研究者

相似试验